Breaking News

Halt on Trump administration’s cuts to NIH funding expanded

February 11, 2025

Today is the last day to get 50% off your first year of STAT+. Subscribe today for the latest news and analysis on cancer research.

Thanks for reading and hope you are taking care.

The Association of American Medical Colleges is one of the plaintiffs that sued the NIH to block research funding cuts.
Adobe

Halt on Trump administration's cuts to NIH research payments expanded nationwide

The temporary restraining order was sought by medical, pharmacy, and public health schools, as well as Boston and New York-area hospitals

By Jonathan Wosen


STAT+ | Mass General Brigham announces largest layoff in its history amid ongoing restructuring

Mass General Brigham is grappling with anticipated financial shortfalls and ongoing operational challenges at its 12 hospitals.

By Jessica Bartlett — Boston Globe


STAT+ | How RFK Jr. could revive a dormant task force to scrutinize vaccine safety

As health secretary, Kennedy could revive a defunct task force to scrutinize the safety of shots given to babies and kids.

By Sarah Owermohle and Rachel Cohrs Zhang



A new NIH funding policy would cause sharp cuts at some research institutions. Stanford University, pictured, said it was set to lose $160 million per year.
Jeff Chiu/AP

STAT+ | Here's how big a hit some universities may take if NIH slashes support for indirect research costs

Documents analyzed by STAT show that big losers under the NIH's cuts to "indirect costs" include Stanford, Vanderbilt, Cornell, the UT system.

By Angus Chen and Jonathan Wosen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments